NCT07656727Phase 2Active not recruiting

A Phase 2 Study to Evaluate the Pharmacodynamics, Safety and Tolerability of BGE-102 in Participants With Obesity and Cardiovascular Risk Factors

Study sponsor: BioAge Labs, Inc. · BIOA

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-11-30Estimated
Enrollment · participants160Estimated
Source updated2026-09-10Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source